The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide.
Br J Dermatol
; 177(3): 858-859, 2017 Sep.
Article
em En
| MEDLINE
| ID: mdl-27943236
ABSTRACT
Hidradenitis suppurativa (HS) is a cutaneous disease associated with systemic inflammation, obesity and metabolic syndrome. Effective treatment options are limited. The antidiabetic agents, incretins, have been used successfully to treat psoriasis - a disease also associated with metabolic syndrome. We report the use of liraglutide, a glucagon-like peptide-1 agonist, in a patient with HS, leading to subsequent weight loss and improvement in disease control. To our knowledge, this is the first report of liraglutide used in the treatment of HS.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Hidradenite Supurativa
/
Liraglutida
/
Hipoglicemiantes
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article